Strive Mid-Cap ETF Rating Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Strive Mid-Cap ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.STXM Aggregate RatingModerate Buy 2.77Holdings in STXM have an aggregate rating of Moderate Buy based on 373 analyst ratings issued in the past year covering 23 companies (12.7% of the portfolio).STXM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Strive Mid-Cap ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 STXM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.69%FLEXFlex$136.854.2572 of 5 stars2.92$115.70 -15.5%12Gap Up0.69%CWCurtiss-Wright$758.94-0.2%3.1066 of 5 stars2.50$749.67 -1.2%6Positive NewsAnalyst Forecast0.68%CASYCasey's General Stores$797.424.7551 of 5 stars2.65$939.29 17.8%20Positive NewsInsider Trade0.60%AERAercap$147.93+0.1%3.7515 of 5 stars2.80$163.13 10.3%10Gap Down0.60%UTHRUnited Therapeutics$555.914.5142 of 5 stars2.85$619.42 11.4%13Trending NewsInsider Trade0.59%WWDWoodward$418.023.6737 of 5 stars2.94$393.00 -6.0%16Positive NewsGap Up0.58%KEYKeyCorp$22.99-0.1%4.9938 of 5 stars2.55$46.55 102.5%20Gap Up0.56%ALBAlbemarle$135.27-0.2%4.6927 of 5 stars2.59$199.58 47.5%27Analyst Forecast0.56%XPOXPO$206.19-0.1%3.3141 of 5 stars2.83$218.10 5.8%24Analyst Upgrade0.55%USFDUS Foods$104.04-0.2%2.6773 of 5 stars2.69$105.50 1.4%13News CoverageAnalyst DowngradeGap Down0.55%BURLBurlington Stores$313.49+0.1%3.7997 of 5 stars2.75$353.56 12.8%200.54%MTZMasTec$374.40+0.3%4.4932 of 5 stars2.90$461.06 23.1%21News CoverageAnalyst ForecastGap Up0.54%NVTnVent Electric$152.29+0.1%4.8532 of 5 stars3.07$189.50 24.4%15Positive NewsGap Up0.54%ATIATI$188.030.0%3.7605 of 5 stars3.10$168.88 -10.2%10Positive NewsAnalyst ForecastAnalyst RevisionGap Up0.53%BGBunge Global$106.54+0.1%3.9847 of 5 stars2.73$132.67 24.5%11Negative News0.52%CHRWC.H. Robinson Worldwide$189.854.0355 of 5 stars2.65$195.35 2.9%23News CoverageAnalyst Forecast0.52%CRSCarpenter Technology$597.44+0.0%3.7188 of 5 stars2.80$481.75 -19.4%10Positive NewsAnalyst ForecastAnalyst RevisionGap Up0.50%ENTGEntegris$146.663.5437 of 5 stars2.55$156.56 6.7%11Positive NewsAnalyst Forecast0.50%BWXTBWX Technologies$190.58-0.3%4.3658 of 5 stars2.73$228.00 19.6%15Positive News0.49%SNASnap-On$412.090.0%3.2739 of 5 stars2.57$387.67 -5.9%7Positive NewsInsider Trade0.47%NXTNextpower$112.844.5083 of 5 stars2.80$148.69 31.8%25Analyst ForecastGap Up0.46%RVMDRevolution Medicines$189.241.9029 of 5 stars3.00$135.39 -28.5%22News CoverageAnalyst ForecastInsider Trade0.46%THCTenet Healthcare$204.28+0.3%4.282 of 5 stars2.82$244.32 19.6%22Positive NewsGap Down This page (NYSEARCA:STXM) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strive Mid-Cap ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Strive Mid-Cap ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.